XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 16, 2022
Aug. 31, 2023
Jul. 31, 2022
May 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Risk-free interest rates         3.76% 2.29%  
Expected life (in years)         6 years 3 months 5 years 11 months 23 days  
Expected Volatility         105.99% 106.85%  
Dividend yield         0.00% 0.00%  
Share based payment award description     the achievement of performance minimum, target, and maximum goals of (i) 90% of revenue goal; (ii) 100% of revenue goal; and (iii) exceed revenue goal by up to 150%, respectively, during fiscal year 2022 the Company of average market capitalization minimum, target, and maximum goals of (i) $300 million; (ii) $400 million; and (iii) $500 million, respectively, during the period beginning on January 1, 2022 and ending on December 31, 2024      
Increase in fair value         $ 58,500    
Number of restricted stock awards, shares   9,091          
Number of restricted stock awards, value   $ 36,000          
Vita Graft [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Vested percentage     50.00% 50.00%      
Determal O [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Vested percentage     50.00% 50.00%      
Determa CNI [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based payment award vesting rights description The remaining 50% is eligible to vest on December 31, 2023, since the Company completed the LCD submission for DetermaCNI on December 16, 2022            
Performance Shares [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based payment award description             50
Performance Shares [Member] | Executive Officers And Employees [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based awards vesting     23,750 61,875      
Market Based Awards [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Risk-free interest rates         2.72%    
Expected life (in years)         2 years 7 months 6 days    
Expected Volatility         95.00%    
Dividend yield         0.00%    
Market Based Awards [Member] | Executive Officers And Employees [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Share based awards vesting       12,500      
Monte Carlo Valuation Technique [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Risk-free interest rates         4.81%   2.00%
Expected life (in years)         6 years 2 months 8 days   2 years 9 months 18 days
Expected Volatility         91.00%   100.00%
Dividend yield         0.00%   0.00%
Monte Carlo Valuation Technique [Member] | Minimum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Fair value grants         $ 1.09    
Monte Carlo Valuation Technique [Member] | Maximum [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Fair value grants         $ 1.74    
2010 Stock Option Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized         260,000    
2018 Incentive Plan [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of shares authorized         1,050,000    
Number of shares available for grant         387,000    
Performance-Based Options [Member]              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Grant date fair value         $ 156,000   $ 117,625
Stock option grant   120,000